Olopatadine hydrochloride in children: efficacy and safety for perennial allergic rhinitis

References

• Bousquet J. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008;63:30-43
   Google Scholar
• Fireman P. Therapeutic approaches to allergic rhinitis: treating the child. J Allergy Clin Immunol 2000;105:S616-21
   PubMed Web of Science ®Google Scholar
• Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 2001;108:S9-15
   PubMed Web of Science ®Google Scholar
• Kaise T, Karasawa A. Olopatadine hydrochloride (Allelock®): inhibitory effect on sensory nerve activation and effectiveness in reducing itching associated with allergic rhinitis, urticaria and skin disease. Allergy Pract 2002;22:50-63
   Google Scholar
• Shah SR, Nayak A, Ratner P, et al. Effect of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescent and adults. Clin Ther 2009;31:99-107
   PubMed Web of Science ®Google Scholar
• Ratner PH, Hampel FC, Amar NJ, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 2005;95:474-9
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Hampel FC, Ratner PH, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2005;95:600-6
   PubMed Web of Science ®Google Scholar
• Berger W, Abelson MB, Gomes PJ, et al. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol 2005;95:361-71
   PubMed Web of Science ®Google Scholar
• Abelson MB, Turner D. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis. Clin Ther 2003;25:931-47
   PubMed Web of Science ®Google Scholar
• Kimihiro Okubo, Kohtaro Baba. A double-blind non-inferiority clinical study of montelukast, a cystenil leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis. Allergol Int 2008;57:383-90
   PubMedGoogle Scholar
• Hitoshi Takahashi, Yan Zhang, Eishin Morita. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Arch Dermatol Res 2008;300:291-5
   PubMed Web of Science ®Google Scholar
• Enomoto T, Lu H-Q, Yin M, et al. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. J Investig Allergol Clin Immunol 2009;19:299-305
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Tanigawara Y, Suzuki I, et al. A phase-III double-blind comparative study of loratadine syrup in children with perennial allergic rhinitis – non-inferiority versus ketotifen fumarate dry syrup. J Clin Therap Med 2007;23:965-90
   Google Scholar
• Baba K. Efficacy and safety of fexofenadine hydrochloride in children with perennial allergic rhinitis – comparison with ketotifen fumarate dry syrup. Practica Oto-Rhino-Laryngologica 2007;Suppl. 119:1-20
   Google Scholar
• Wahn U, Meltzer EO, Finn AF Jr, et al. Fexofenadine is efficacious and safe in children (aged 6–11 years) with seasonal allergic rhinitis. J Allergy Clin Immunol 2003;111:763-9
   PubMed Web of Science ®Google Scholar
• de Blic J, Wahn U, Billard E, et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol 2005;16:267-75
   PubMed Web of Science ®Google Scholar
• Pearlman DS, Lumry WR, Winder JA, et al. Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study. Clin Pediatr 1997;36:209-15
   PubMed Web of Science ®Google Scholar
• Potter PC, for the Paediatric Levocetirizine Study Group. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol 2005;95:175-80
   PubMed Web of Science ®Google Scholar